These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24623623)

  • 1. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V; Kadi A; Mouna L; Fenaux H; Cechura H; Rafek R; Di Ciccone JL; Warnakulasuriya F; Vauloup-Fellous C
    J Virol Methods; 2024 Sep; 329():115002. PubMed ID: 39067186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the new ARCHITECT EBV assays considering different testing algorithms.
    Sickinger E; Berth M; Vockel A; Braun HB; Oer M; Buenning C
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):310-6. PubMed ID: 24809858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.
    Guerrero-Ramos A; Patel M; Kadakia K; Haque T
    Clin Vaccine Immunol; 2014 Jun; 21(6):817-23. PubMed ID: 24695777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
    de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.
    Lupo J; Germi R; Semenova T; Buisson M; Seigneurin JM; Morand P
    Clin Vaccine Immunol; 2012 Jun; 19(6):929-34. PubMed ID: 22539474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.
    Binnicker MJ; Jespersen DJ; Harring JA; Rollins LO; Beito EM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1410-3. PubMed ID: 18632919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Abbott Architect
    François C; Segard C; Bouvier M; Stefanski M; Pannier C; Zawadzki P; Roussel C; Hecquet D; Duverlie G; Brochot E; Castelain S
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):96-101. PubMed ID: 29198371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical profile problem in serological diagnosis of EBV].
    Varıcı Balcı FK; Özbek ÖA; Sayıner AA
    Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three different assays for the assessment of Epstein Barr Virus immunological status.
    Altuglu I; Bozkurt H; Samlioglu P; Zeytinoglu A
    New Microbiol; 2007 Oct; 30(4):393-8. PubMed ID: 18080674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.